QureBio Ltd. to Showcase its Q-1802 Clinical Advances at 202

/PRNewswire/ -- QureBio Ltd., a clinical-stage biopharmaceutical company focusing on bi-specific antibodies and other engineered bio-therapeutics for the...

Related Keywords

Shanghai , China , United States , Shenzhen , Guangdong , Peking , Beijing , Chicago , Illinois , Hangzhou , Zhejiang , Lin Shen , Jundu , Shanxi , American , Viva Bio , Jifang Gong , American Society Of Clinical Oncology , University Cancer Hospital , Department Of Gastrointestinal Oncology , Qurebio Ltd , Hengrui Pharmaceuticals , Shanghai Pudong Kechuang Group , Prnewswire Qurebio Ltd , Bocom Industrial Investment Hangzhou Equity Partnership , Shenzhen Capital Group , Suzhou Oriza Holdings , Fbio Ltd , American Society , Clinical Oncology , Annual Meetings , Peking University Cancer Hospital , Meeting Abstracts , Gastrointestinal Oncology , Developmental Therapeutics , Chicago Time , Viva Bio Innovator , Jundu Investment , Watson Capital , Bocom Industrial Investment , Equity Investment Partnership , Zhuhai Longmen Capital Management , Shenzhen Lihe Hongxin Venture , Three Rivers , Precision Scientific , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Pharmaceuticals , Trade Show News ,